JULIA STORTI: Open Payments
NPI 1679683916 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,334 in 102 payments from 23 companies in 2025. Trend: 2023 $1,407 · 2024 $2,206 · 2025 $2,334
Food & beverage: $2,188Education: $146
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 11 | $403 |
| Janssen Biotech, Inc. | 17 | $297 |
| ABBVIE INC. | 16 | $240 |
| UCB, Inc. | 6 | $205 |
| Arcutis Biotherapeutics, Inc. | 10 | $139 |
| Organon LLC | 6 | $119 |
| Regeneron Healthcare Solutions, Inc. | 4 | $115 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $95 |
| Botanix SB Inc | 4 | $91 |
| LEO Pharma Inc. | 3 | $87 |
Products named: DUPIXENT, TREMFYA, Bimzelx, Zoryve, SKYRIZI, RINVOQ, SOFDRA, ADBRY.
Industry payments across FL — which companies pay providers there.
